Next Generation Sequencing (NGS) Market – Global Trends and Global Forecast to 2024

SUBSCRIBE FOR UPDATED REPORTS

Get great contents delivered straight to your inbox everyday, just a click away, Sign Up Now.
Name
Email
US : +1-888-387-2818
UK : +44 208 089 1725

Global Next Generation Sequencing (NGS) Market – Industry Trends and Forecast to 2024

Global
Upcoming Reports
Global Next-Generation Sequencing (NGS) Market
  • No of pages :
    350
  • No of Figures:
    50
  • No of Tables:
    250
  • Report Type:
    Upcoming

Global Next Generation Sequencing (NGS) Market,By Product (Instruments (Hiseq series, Miseq series, ION Torrent, SOLiD, Pacbio Rs II and Sequel system), Consumables (Sample preparation consumables, Other), Services (Sequencing services, Data management services), by Application (Diagnostics, Drug Discovery , Biomarker Discovery , Precision Medicine , Agriculture & Animal Research), by End-user (Hospitals & Clinics, Research Centers and Academic & Government Institutes, and Pharmaceutical & Biotechnology Companies), by Geography (North America, Europe, Asia-Pacific, Europe, South America, Middle East and Africa) – Industry Trends and Forecast to 2024

Market Analysis: Global Next Generation Sequencing (NGS) Market

The Global Next Generation Sequencing (NGS) Market accounted to USD 13.51 billion by 2022 growing at a CAGR of 22.7% during the forecast period of 2017 to 2024. The upcoming market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Market Definition: Global Next Generation Sequencing (NGS) Market

Next Generation Sequencing (NGS) Market is also termed as high-throughput sequencing. It is a DNA sequencing technology in which millions and billions DNA strands are sequenced. It has revolutionized genomic research, as it minimizes the requirement for fragment-cloning methods used in Sanger sequencing of genomes.

Major Market Drivers and Restraints:

  • Advanced technology in NGS platforms and increased applications of NGS.
  • Increased in adoption of NGS among research laboratories and academic institutes.
  • Efficient speed, cost, and accuracy of the technology.
  • Drug discovery applications in NGS technology are some of the factors which drives the market.
  • R&D investments are another factor to grow the market.
  • Lack of skilled technicians.
  • Accuracy and uniformity concerns in diagnostics testing limits the growth of market.
  • Interpretation of complex data and issues regarding storage of sequencing data hinders the market.
  • Legal and ethical issues are the challenge in the growing market.
  • Emerging markets are proving the new opportunities in the growth of the market.
  • Application of NGS in precision medicines & Biomarker discovery.

Market Segmentation: Global Next Generation Sequencing (NGS) Market

The Next Generation Sequencing (NGS) Market is segmented in Product and Services, which is segmented in Consumables, which is further bifurcated in Sample Preparation, which is again further classified in DNA Fragmentation, End Repair, A-Tailing, and Size Selection, Library Preparation & Target Enrichment, Quality Control and other consumables, Platforms, which is classified in HiSeq, MiSeq, Ion Torrent, SOLiD, Pacbio Rs II and Sequel System and other sequencing platforms, Sequencing Services, which is classified in RNA Sequencing, Whole Exome Sequencing, Whole Genome Sequencing, Targeted Sequencing, Chip Sequencing, De Novo Sequencing, Methyl Sequencing, Amplicon sequencing, Epigenomics, Digital Karyotyping and Metagenomics, Data Managemnet Services, which is further bifurcated in NGS Data Analysis Services, NGS Data Analysis Software & Workbenches, NGS Storage, Management and Cloud Computing Solutions.

By Technology the NGS market is segmented in Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Pyrosequencing, Single Molecule Real Time Sequencing.

By Application the market is classified in Diagnostics, Drug Discovery, Biomarker Discovery, Precision Medicine, Agriculture and Animal Research, Reproductive Health, Personalized Medicine, Oncology, Clinical Investigation, Forensics,. HLA typing/Immune System Monitoring, Metagenomics, Epidemiology.

By End Users the market is spread in Hospitals & Healthcare institutions, Biotech & Pharma firms, Academic & Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, Clinical Research.

By Geography the market covers the 5 major regions such as North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The major countries of the market are U.S., Canada, Mexico, Germany,France, Italy, Spain, India, Japan, China, Australia, South Korea, Taiwan, Brazil, Turkey, Suadi Arabia and South Africa among others. North America is dominating the market followed by the Europe.

Competitive Analysis: Global Next Generation Sequencing (NGS) Market

The Next Generation Sequencing (NGS) Market is highly fragmented and is based on new product launches and clinical results of products. Hence the major players have used various strategies such as new product launches, clinical trials, market initiatives, high expense on research and development, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of Global Next-Generation Sequencing (NGS) Market for global, Europe, North America, Asia Pacific and South America.

Major Market Competitors: Global Next Generation Sequencing (NGS) Market

Some of the major players operating in Global Next Generation Sequencing (NGS) Market are Illumina, Inc., Thermo Fisher Scientific Inc., Pacific Biosciences of California, Inc., QIAGEN, BGI, Oxford Nanopore Technologies, PerkinElmer, Inc., GATC Biotech AG, Agilent Technologies, F. Hoffmann-La Roche Ltd, Macrogen, Inc., Eurofins Scientific, Biomatters Limited, Genomatix GmbH, PierianDx, Myriad Genetics, Inc., Partek Incorporated, DNASTAR, Inc., New England Biolabs among others.

Research Methodology: Global Next Generation Sequencing (NGS) Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please Request an analyst call or drop down your enquiry.

Demand Side Primary Contributors: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.

Supply Side Primary Contributors: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.

Choose Licence Type

Enterprise, Single User

TABLE OF CONTENTS GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET

1. INTRODUCTION

1.1 OVERVIEW OF THE GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET
1.2 CURRENCY AND PRICING
1.3 LIMITATION
1.4 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 KEY TAKEAWAYS

2.2 ARRIVING AT THE GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET SIZE

2.2.1 MARKET CRACKDOWN APPROACH
2.2.2 COMPANY REVENUE AND MARKET SHARE ANALYSIS
2.2.3 DATA TRIANGULATION
2.2.4 KEY DATA POINTS FROM PRIMARY SOURCES
2.2.5 KEY DATA POINTS FROM SECONDARY SOURCES
2.2.6 PORTER’S FIVE FORCES MATRIX
2.2.7 PEST ANALYSIS
2.2.8 EPIDEMIOLOGY FORECASTING MODELS

2.3 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET: RESEARCH SNAPSHOT

2.4 ASSUMPTIONS

3 MARKET OVERVIEW

3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 CHALLENGES

4 EXECUTIVE SUMMARY

5 PREMIUM INSIGHTS

6 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET, BY PRODUCT

6.1 OVERVIEW

6.2 INSTRUMENTS

6.2.1 HISEQ SERIES
6.2.2 MISEQ SERIES
6.2.3 ION TORRENT
6.2.4 SOLID
6.2.5 PACBIO RS II
6.2.6 SEQUEL SYSTEM

6.3 CONSUMABLES

6.3.1 SAMPLE PREPARATION CONSUMABLES
6.3.2 OTHER

6.4 SERVICES

6.4.1 SEQUENCING SERVICES
6.4.2 DATA MANAGEMENT SERVICES

7 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET, BY APPLICATION

7.1 OVERVIEW
7.2 DIAGNOSTICS
7.3 DRUG DISCOVERY
7.4 BIOMARKER DISCOVERY
7.5 PRECISION MEDICINE
7.6 AGRICULTURE & ANIMAL RESEARCH

8 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET, BY END-USER

8.1 OVERVIEW
8.2 HOSPITALS & CLINICS
8.3 RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES
8.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES

9 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET, BY GEOGRAPHY

9.1 COUNTRYWISE GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)

9.1.1 NORTH AMERICA

9.1.1.1 U.S.
9.1.1.2 CANADA
9.1.1.3 MEXICO

9.1.2 EUROPE

9.1.2.1. GERMANY
9.1.2.2 FRANCE
9.1.2.3 U.K.
9.1.2.4 ITALY
9.1.2.5 SPAIN
9.1.2.6 RUSSIA
9.1.2.7 TURKEY
9.1.2.8 BELGIUM
9.1.2.9 NETHERLANDS
9.1.2.10 SWITZERLAND
9.1.2.11 REST OF EUROPE

9.1.3 ASIA-PACIFIC (APAC)

9.1.3.1 JAPAN
9.1.3.2 CHINA
9.1.3.3 SOUTH KOREA
9.1.3.4 INDIA
9.1.3.5 AUSTRALIA
9.1.3.6 SINGAPORE
9.1.3.7 THAILAND
9.1.3.8 MALAYSIA
9.1.3.9 INDONESIA
9.1.3.10 PHILIPPINES
9.1.3.11 REST OF APAC

9.1.4 LATIN AMERICA

9.1.4.1 BRAZIL
9.1.4.2 REST OF LATIN AMERICA

9.1.5 MIDDLE EAST AND AFRICA

9.1.5.1 SOUTH AFRICA
9.1.5.2 REST OF MIDDLE EAST AND AFRICA
9.2 KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES

10 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET: COMPETITIVE LANDSCAPE

10.1. GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET: COMPANY SHARE ANALYSIS
10.2. NORTH AMERICA NEXT GENERATION SEQUENCING (NGS) MARKET: COMPANY SHARE ANALYSIS
10.3. EUROPE NEXT GENERATION SEQUENCING (NGS) MARKET: COMPANY SHARE ANALYSIS
10.4. APAC NEXT GENERATION SEQUENCING (NGS) MARKET: COMPANY SHARE ANALYSIS
10.5. MEA NEXT GENERATION SEQUENCING (NGS) MARKET: COMPANY SHARE ANALYSIS
10.6. SOUTH AMERICA NEXT GENERATION SEQUENCING (NGS) MARKET: COMPANY SHARE ANALYSIS
10.7. MERGERS & ACQUISITIONS
10.8. NEW PRODUCT DEVELOPMENT & APPROVALS
10.9. EXPANSIONS
10.10. REGULATORY CHANGES
10.11. PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS

11 GLOBAL NEXT GENERATION SEQUENCING (NGS) MARKET, COMPANY PROFILES

11.1 QIAGEN

11.1.1 COMPANY OVERVIEW
11.1.2 FINANCIAL ANALYSIS
11.1.3 PRODUCT MATRIX
11.1.4 RECENT DEVELOPMENTS
11.1.5 DATABRIDGE ANALYSIS

11.2 BGI

11.2.1 COMPANY OVERVIEW
11.2.2 FINANCIAL ANALYSIS
11.2.3 PRODUCT MATRIX
11.2.4 RECENT DEVELOPMENTS
11.2.5 DATABRIDGE ANALYSIS

11.3 OXFORD NANOPORE TECHNOLOGIES

11.3.1 COMPANY OVERVIEW
11.3.2 FINANCIAL ANALYSIS
11.3.3 PRODUCT MATRIX
11.3.4 RECENT DEVELOPMENTS
11.3.5 DATABRIDGE ANALYSIS

11.4 F. HOFFMANN-LA ROCHE LTD

11.4.1 COMPANY OVERVIEW
11.4.2 FINANCIAL ANALYSIS
11.4.3 PRODUCT MATRIX
11.4.4 RECENT DEVELOPMENTS
11.4.5 DATABRIDGE ANALYSIS

11.5 PERKINELMER INC.

11.5.1 COMPANY OVERVIEW
11.5.2 FINANCIAL ANALYSIS
11.5.3 PRODUCT MATRIX
11.5.4 RECENT DEVELOPMENTS
11.5.5 DATABRIDGE ANALYSIS

11.6 GATC BIOTECH AG

11.6.1 COMPANY OVERVIEW
11.6.2 FINANCIAL ANALYSIS
11.6.3 PRODUCT MATRIX
11.6.4 RECENT DEVELOPMENTS
11.6.5 DATABRIDGE ANALYSIS

11.7 AGILENT TECHNOLOGIES

11.7.1 COMPANY OVERVIEW
11.7.2 FINANCIAL ANALYSIS
11.7.3 PRODUCT MATRIX
11.7.4 RECENT DEVELOPMENTS
11.7.5 DATABRIDGE ANALYSIS

11.8 MACROGEN, INC.

11.8.1 COMPANY OVERVIEW
11.8.2 FINANCIAL ANALYSIS
11.8.3 PRODUCT MATRIX
11.8.4 RECENT DEVELOPMENTS
11.8.5 DATABRIDGE ANALYSIS

11.9 BIO-RAD LABORATORIES, INC.

11.9.1 COMPANY OVERVIEW
11.9.2 FINANCIAL ANALYSIS
11.9.3 PRODUCT MATRIX
11.9.4 RECENT DEVELOPMENTS
11.9.5 DATABRIDGE ANALYSIS

11.10 DNASTAR, INC.,

11.10.1 COMPANY OVERVIEW
11.10.2 FINANCIAL ANALYSIS
11.10.3 PRODUCT MATRIX
11.10.4 RECENT DEVELOPMENTS
11.10.5 DATABRIDGE ANALYSIS

11.11 BIOMATTERS LIMITED.

11.11.1 COMPANY OVERVIEW
11.11.2 FINANCIAL ANALYSIS
11.11.3 PRODUCT MATRIX
11.11.4 RECENT DEVELOPMENTS
11.11.5 DATABRIDGE ANALYSIS

11.12 PARTEK INCORPORATED

11.12.1 COMPANY OVERVIEW
11.12.2 FINANCIAL ANALYSIS
11.12.3 PRODUCT MATRIX
11.12.4 RECENT DEVELOPMENTS
11.12.5 DATABRIDGE ANALYSIS

12 APPENDIX

13 ABOUT DATA BRIDGE MARKET RESEARCH

Please fill in the below form for detailed List of Tables

Please fill in the below form for detailed List of Figures

Please fill in the below form and our sales representatives will get back to you Shortly

Please fill in the below form and our sales representatives will get back to you Shortly

`